If you research DXB from 11 March on an efficatiecy announcement to a TH and a capital raise on 12 March to the SP today, you'll find a 100% gain in a little over 3 months...
Both DXB and BOT feature heavily as broker tips.
We will now soon what the purpose of the raise is soon.
Potentially they may be considering a strategic tie up with Kaken (Ecclock) for advancement into Asia as a scenario.......after all they were there March time....
Ann: FDA Approves Sofdra, page-164
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.010(2.63%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.5¢ | 36.0¢ | $3.051M | 8.277M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 465836 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.5¢ | 301865 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |